We are happy to announce our participation in the 51st annual meeting of the Japanese Society of Toxicology (JSOT 2024), slated to be held at the Fukuoka International Congress Center in Japan from July 3rd to 5th, 2024.
Our Commercial Director, Elisabet Mateu, and Market Access Specialist, Claudia Miguel, will be showcasing the power of zebrafish for safety assessment of agrochemicals & biocides, pharmaceuticals, and industrial chemicals.
Don't miss Elisabet's presentations:
- Seminar titled "ZeClinics, your high-throughput screenings NAM ally for regulatory (eco)toxicology and human safety,". July 3, Wednesday 6:00 PM (JST).
- Poster titled "Determining the added value of the zebrafish model in Developmental Toxicity based of ICH guideline S5 (R3)". July 4, Thursday 5:15 PM (JST).
As well as Claudia's presentation:
- Seminar titled "Zebrafish embryos as a model for developmental toxicology assessment." July 3, Wednesday 6:30 PM (JST).
We look forward to meeting you at JSOT 2024 and discussing potential collaborations!
ZeClinics' participants:
Elisabet Mateu, Commercial Director
Claudia Miguel, Market Access Specialist